web analytics
16.3 C
Munich
Saturday, May 28, 2022

Cryomass Technologies Inc (OTCMKTS: CRYM) Heating Up as Co Builds Out Patented CryoCann 500 CF to Process Cannabis & Other High Value Plants

Cryomass Technologies Inc (OTCMKTS: CRYM) has been running up the charts ever since it tested the $0.20 mark again earlier this year. The stock hit a high of $0.64 last year followed by several months of choppy waters but is now marching northbound once again. CRYM is a sec filer and fully reporting OTCQB venture exchange Company that recently completed a $10.3 million equity financing. Makers of the revolutionary CryoCann 500 CF for the handling of harvested cannabis, hemp and other high-value plant material. The patented technology could revolutionize the cannabis industry; it can be trucked to any field where commercial hemp or cannabis is being harvested. The CryoCann 500 CF is optimized for the rapid capture (within minutes after plant harvesting) of fully intact cannabis and hemp trichomes, as well as terpenes. Rapid capture should enable cannabis and hemp producers to dramatically reduce costs, increase end-product yields and enhance product purity.  

Currently the team at Cryomass is busy building out the first functional “beta” machine, expected to be ready for field testing by a third-party cannabis producer this summer. Management fully expects the CryoMass system to deliver a compelling combination of cost and time savings while enhancing product quality and quantity for largescale cultivators and processors of hemp and cannabis. The CryoCann 500 CF addresses an enormous market; production and processing of hemp and cannabis is a huge, worldwide industry. In the U.S., for example, the wholesale value of the cannabis crop from just the 11 states permitting adult-use and medical cannabis exceeds $6 billion annually. Growth in the U.S. and in the worldwide market is likely fed in part by the growing acceptance of medicinal cannabis products and anticipated legislative changes in various jurisdictions worldwide. 

Cryomass Technologies Inc (OTCMKTS: CRYM) owner of superior, patented technology is building out its industry shattering CryoCann 500 CF for the handling of harvested cannabis, hemp and other high-value plant material. The company owns patented technology that utilizes liquid nitrogen to fully separate, collect and protect the high-value materials and essential compounds from the harvested plant. Building on that technology, the company’s technical team has completed an initial design for the CryoCann 500 CF system. The CryoCann 500 CF is optimized for the rapid capture (within minutes after plant harvesting) of fully intact cannabis and hemp trichomes, as well as terpenes. Rapid capture should enable cannabis and hemp producers to dramatically reduce costs, increase end-product yields and enhance product purity. The resulting sift can be warehoused for extended periods, or further processed into consumer products. The company believes that efficiencies delivered by the CryoCann 500 CF will trigger industry-wide changes in the handling and processing of harvested cannabis and hemp. It also is exploring the application of the underlying technology to a broad range of industries that handle high-value materials that could benefit from precision capture methods. 

The CryoMass Refinement System uses patented technology to instantly freeze the whole plant and fully separates the trichomes, including THC, CBD and terpenes, from the biomass. The patented process renders up to a 90% dried output material with a dramatic reduction in biomass volume of up to 80%. The resulting high purity, refined “cryogenic sift” can be warehoused for extended periods of time or further processed into cannabis and hemp distillate or isolate for use in consumer products. 

Just last week the Company contracted with an independent engineering and manufacturing firm to refine the design of the CryoCann 500 CF for the handling of harvested hemp, cannabis and other high-value plants. The system exploits CryoMass’s U.S.-patented process for the controlled application of liquid nitrogen to stabilize and separate the structural elements of gross plant material. The three-dimensional advantage achievable with the CryoMass system can as much as double a crop’s wholesale value. The device currently under development is scaled for highway transportability and is being optimized for the low-cost collection of fully intact hemp and cannabis trichomes. It can be used within minutes after plants have been cut and can also efficiently capture trichomes from fresh frozen or even dried plant parts, including trim. The device’s through-put capacity is expected to be approximately 600 kilograms of gross plant material per hour. 

To Find out the inside Scoop on CRYM Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

CRYM

The advanced design for the equipment has been completed, and testing of a prototype machine is currently underway. The engineering and manufacturing firm has indicated that it has the capacity to build 10 to 15 such devices per month. On September 30th CryoMass was granted an additional patent for its process from the Chinese Intellectual Property Office. The Company currently is taking steps to gain further protection for our intellectual property through the European Union Intellectual Property Office and several other international jurisdictions. 

On November 11th CryoMass retained a second engineering and manufacturing firm to independently develop a separate machine design that applies its patented process. Management expects their work to help strengthen the power and robustness of CryoMass technology. In addition, it opens a channel to a second manufacturing source. 

On November 17th CRYM announced the completion of a $10.3 million equity financing. The financing and the earlier conversion of substantially all the company’s debt into common stock left the Company with a strong balance sheet and adequate resources for our planned business development during the coming twelve months. In connection with the financing, 1,010,000 shares and 760,000 shares of CryoMass Technologies common stock were purchased by CEO Christian Noël and Chairman of the Board Delon Human, respectively. 

Up next comes beta testing. The first functional “beta” machine is expected to be ready for field testing by a third-party cannabis producer in January 2022. The first production-run machine is expected to be ready for use towards the end of the first quarter 2022. At that moment, management expect sto start helping its first tolling client (fee for service) increase its margins by cutting the cost of handling, processing and refining its hemp or cannabis and increasing the resulting material’s value to formulators of end products. 

Management fully expects the CryoMass equipment currently under development to deliver a compelling combination of cost and time savings while enhancing product quality and quantity for largescale cultivators and processors of hemp and cannabis. The use of a CryoMass system – which can be trucked to and operated on the fields of most large hemp and cannabis growers or be permanently installed at a user’s processing facility – should eliminate many of the costs that come with traditional practices, especially the labor, fuel and capital costs of drying and curing hemp or cannabis that is grown for the extraction of end products. 

The CryoCann 500 CF addresses an enormous market; production and processing of hemp and cannabis is a huge, worldwide industry. In the U.S., for example, the wholesale value of the cannabis crop from just the 11 states permitting adult-use and medical cannabis exceeds $6 billion annually. Growth in the U.S. and in the worldwide market is likely fed in part by the growing acceptance of medicinal cannabis products and anticipated legislative changes in various jurisdictions worldwide. 

For More on CRYM Subscribe Right Now!

Currently trading at a $98 million market cap CRYM has 200,435,331 shares outstanding 114,173,042 of which are restricted. The Company has a decent looking balance sheet and is well funded moving forward thanks to a recent $10.3 million equity financing deal. CRYM is an exciting story currently being promoted by The Crypto Vigilante that is gaining traction in small caps; makers of the revolutionary CryoCann 500 CF for the handling of harvested cannabis, hemp and other high-value plant material. The patented technology could revolutionize the cannabis industry; it can be trucked to any field where commercial hemp or cannabis is being harvested. The CryoCann 500 CF is optimized for the rapid capture (within minutes after plant harvesting) of fully intact cannabis and hemp trichomes, as well as terpenes. Management fully expects the CryoMass system to deliver a compelling combination of cost and time savings while enhancing product quality and quantity for largescale cultivators and processors of hemp and cannabis. The CryoCann 500 CF addresses an enormous market; production and processing of hemp and cannabis is a huge, worldwide industry. In the U.S., for example, the wholesale value of the cannabis crop from just the 11 states permitting adult-use and medical cannabis exceeds $6 billion annually. Growth in the U.S. and in the worldwide market is likely fed in part by the growing acceptance of medicinal cannabis products and anticipated legislative changes in various jurisdictions worldwide. We will be updating on CRYM when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with CRYM.

Sign Up now for our 100% FREE Penny Stock Newsletter

Disclosure: we hold no position in CRYM either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.